The B cell response to citrullinated antigens in the development of rheumatoid arthritis. (Q50129712)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

title

The B cell response to citrullinated antigens in the development of rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

Rene E Toes

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

2

Tom W J Huizinga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Hans Ulrich Scherer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

Georg Schett

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

English

0 references

publication date

8 February 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

157-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in rheumatoid arthritis patients and relatives from Brazil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern Turkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-keratin antibodies in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll‐like receptor 4 and Fcγ receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Toll-like receptor triggering augments activation of human mast cells by anti-citrullinated protein antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Fcγ receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

PADI2 is significantly associated with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Synovial fluid mononuclear cells provide an environment for long-term survival of antibody-secreting cells and promote the spontaneous production of anti-citrullinated protein antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

CD95-Mediated control of anti-citrullinated protein/peptides antibodies (ACPA)-producing plasma cells occurring in rheumatoid arthritis inflamed joints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Isotype distribution of ANTI–CYCLIC citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The ACPA recognition profile and subgrouping of ACPA-positive RA patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The generation of antibody diversity through somatic hypermutation and class switch recombination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Control systems and decision making for antibody production.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Monoclonal anti-citrullinated protein antibodies selected on citrullinated fibrinogen have distinct targets with different cross-reactivity patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated pr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Breach of autoreactive B cell tolerance by post-translationally modified proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Monoclonal antibody against citrullinated peptides obtained from rheumatoid arthritis patients reacts with numerous citrullinated microbial and food proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

In ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein-Barr nuclear antigen-1, strongly cross-react with the peptide β60-74Cit which bears the immunodominant epitope of citrullinated fibrin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The impact of glycosylation on the biological function and structure of human immunoglobulins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Structural Analysis of Variable Domain Glycosylation of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Reveals the Presence of Highly Sialylated Glycans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The amino acid at the X position of an Asn-X-Ser sequon is an important determinant of N-linked core-glycosylation efficiency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The Emerging Importance of IgG Fab Glycosylation in Immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The extensive glycosylation of the ACPA variable domain observed for ACPA-IgG is absent from ACPA-IgM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Role of oligosaccharide residues of IgG1-Fc in Fc gamma RIIb binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

General mechanism for modulating immunoglobulin effector function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Agalactosyl glycoforms of IgG autoantibodies are pathogenic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Galactose terminating oligosaccharides of IgG in patients with primary Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Abnormal glycosylation of serum igg from patients with chronic inflammatory diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Effect of infliximab on the glycosylation of IgG of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin‐17A production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anticitrullinated Protein Antibody, But Not Its Titer, Is a Predictor of Radiographic Progression and Disease Activity in Rheumatoid Arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Anticytokine therapy impacting on B cells in autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Circulating plasmablasts/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Persistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Checkpoints that control B cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Receptor editing and genetic variability in human autoreactive B cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Predominant autoantibody production by early human B cell precursors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Impaired early B cell tolerance in patients with rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Altered immunoglobulin metabolism in systemic lupus erythematosus and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The hydroxy amino acid in an Asn-X-Ser/Thr sequon can influence N-linked core glycosylation efficiency and the level of expression of a cell surface glycoprotein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

CD22 ligation inhibits downstream B cell receptor signaling and Ca(2 ) flux upon activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Siglecs and their roles in the immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

IgG Rheumatoid Factor-Secreting Lymphocytes in Rheumatoid Arthritis: Evaluation of a Haemolytic Plaque-Forming Cell Technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG and IgA B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue

31 March 2020

2 references

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

31 March 2020

12 December 2020

Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Production of Autoantibodies against Citrullinated Antigens/Peptides by Human B Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Ex vivo characterization and isolation of rare memory B cells with antigen tetramers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis: results of a follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2018.10

7 January 2021

inferred from DOI database lookup

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

12 December 2020

Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy.

1 reference

12 December 2020

Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis

1 reference

12 December 2020

Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.

1 reference

12 December 2020

Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope

1 reference

12 December 2020

A Novel HLA-DRB1*10:01-Restricted T Cell Epitope From Citrullinated Type II Collagen Relevant to Rheumatoid Arthritis.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2018.10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29416134 AND SRC:MED&resulttype=core&format=json

14 March 2020

1 reference